8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
📢 Johnson & Johnson filed an 8‑K on Jan 21, 2026 announcing sales and earnings for Q4 and FY ended Dec…
Filed with the SEC on · Summarized by InvestorsBot
📢 Johnson & Johnson filed an 8‑K on Jan 21, 2026 announcing sales and earnings for Q4 and FY ended Dec 28, 2025. Press release attached as Exhibit 99.1. Review the release for reported revenue and EPS. $JNJ #earnings #investing
📄 Item 2.02 confirms the Jan 21, 2026 release (Exhibit 99.1) discloses sales and earnings for the period; the 8‑K text contains no numeric results. See the attached press release for full figures and commentary. $JNJ #earnings #JohnsonAndJohnson
🔎 Investors: read Exhibit 99.1 for Q4/FY2025 revenue, EPS, segment results and any management guidance — those figures will drive near‑term $JNJ outlook. $JNJ #earnings #investing